TrialRespiratory research2020

A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids.

Edward Kerwin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.